Benzinga's Weekend M&A Chatter

The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday February 13 Through Monday February 16, 2015:

:

Intrexon Corporation

announced Friday, it has agreed to acquire European clinical stage biopharmaceutical company, ActoGeniX, for approximately $30 million in cash and $30 million in Intrexon common stock. The deal is expected to close in Q1 2015. Intrexon shares gained $1.05 Friday, closing at $39.30.

:

Endo International PLC

reportedly has expressed in acquiring Salix Pharmaceuticals Ltd

, according to a report from

. Sources say the advances, which include letters sent by Endo to Salix have been rejected, but that Endo remains interested in a deal. Endo joins a growing list of potential suitors for Salix, including Valeant Pharmaceuticals International, Inc.

, which reportedly has arranged financing for a potential deal and Shire plc

, said to be working with advisers on a bid. Salix shares rose 2% Friday, to close at $152.35.

:

Former Motorola Unit, Freescale Semiconductor

, is in sale talks,

. Sources say, the company has hired investment bankers to investigate a potential sale. Samsung Electronics Co. Ltd.

has been mentioned as a potential buyer. A spokesperson for Freescale Semiconductor, could not be reached for comment. Freescale shares closed Friday at $37.53, a gain of 8%.

:

Phillips 66 Partners LP

announced Monday, that it has agreed to acquire Phillips 66'

interests in three pipeline systems, for total consideration of $1.01 billion, including $880 million in cash and 1,726,914 newly issued PSXP units, to be allocated between common units and general partner units in a proportion allowing the general partner to maintain its 2 percent general partner interest. The deal is expected to close in early March 2015. Phillips 66 Partners shares closed Friday at $78.83, a gain of 2.5%.